ClinicalTrials.Veeva

Menu

Erector Spinae Plane Block in Liver Transplantation Donors

M

Medipol University

Status

Completed

Conditions

Pain, Postoperative

Treatments

Procedure: Erector Spinae Plane Block
Procedure: Intravenous fentanyl patient control device

Study type

Interventional

Funder types

Other

Identifiers

NCT05406388
MEDIPOLU-973

Details and patient eligibility

About

Living donor liver transplantation has become a common treatment option for patients with end-stage liver disease. Donor hepatectomy is associated with significant postoperative pain due to inverted L-shaped incision. Therefore adequate analgesia is important for recovery.

Erector Spinae Plane Block (ESPB) is a safe anesthesia technique used to provide postoperative analgesia. This study aimed to compare the novel ultrasound-guided ESPB technique with controls in terms of postoperative opioid consumption and postoperative pain control on donor patients.

Enrollment

41 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Donor patients scheduled for elective hepatectomy in liver transplantation surgery
  • ASA I-II
  • Patients who are aged between 18-65

Exclusion criteria

  • Patients who do not accept the procedure
  • Skin infection at the site of Erector Spina Plan Block area
  • Coagulation disorder or using anticoagulant drugs
  • Known local anesthetics and opioid allergy
  • Severe pulmonary and/or cardiovascular problems
  • Substance addiction or known psychiatric or mental problems
  • Chronic painkiller usage
  • Pregnancy or lactation

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

41 participants in 2 patient groups

Erector Spinae Plane Block
Active Comparator group
Description:
Erector Spinae Plane Block for Postoperative Analgesia
Treatment:
Procedure: Erector Spinae Plane Block
Control group
Active Comparator group
Description:
No regional anesthesia technique will be applied to the control group.
Treatment:
Procedure: Intravenous fentanyl patient control device

Trial contacts and locations

1

Loading...

Central trial contact

Tumay Uludag Yanaral, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems